stockportfolio.pro
Stocks / ADUS vs RAPP
ADUS vs RAPP
Addus HomeCare Corporation and Rapport Therapeutics, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Addus HomeCare Corporation (ADUS) | Rapport Therapeutics, Inc. (RAPP) | |
|---|---|---|
| Market cap | $1.7B | $1.7B |
| Revenue (latest FY) | $1.42B | $0 |
| Net income (latest FY) | $95.91M | $-111.48M |
| Revenue growth (5y CAGR) | 13.2% | — |
| Net margin | 6.7% | — |
| Return on equity | 8.8% | -23.0% |
| P/E ratio | 17.1 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 10 | 0 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ADUS — free Open RAPP — freeFrequently asked questions
Which is bigger, ADUS or RAPP?
Addus HomeCare Corporation is larger by market capitalization — $1.7B versus $1.7B.
Which grows faster, ADUS or RAPP?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.